Home › Brain Diseases › Pennsylvania › Philadelphia
Brain Diseases clinical trials in Philadelphia, PA
5 studies for Brain Diseases are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
CoMind Early Feasibility Study
RecruitingObservational study
- University of Pennsylvania Hospital, Philadelphia
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Pennsylvania Hospital, Philadelphia
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Philadelphia
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
RecruitingObservational studyHealthy volunteers welcome
- The Children's Hospital of Philadelphia, Philadelphia
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Children's Hospital of Philadelphia (CHOP), Philadelphia
About Brain Diseases
Brain diseases affect different functions of the body from memory, speech, thinking clearly, how well the different organs work, or even movement.
More about Brain Diseases on MedlinePlus
Brain Diseases trials in other cities
- New York City, NY7 studies
- St. Louis, MO7 studies
- Orlando, FL7 studies
- Boston, MA7 studies
- Washington, DC6 studies
- Pittsburgh, PA6 studies
- Miami, FL6 studies
- Houston, TX6 studies
- San Diego, CA5 studies
- Akron, OH4 studies
- West Palm Beach, FL4 studies
- Atlanta, GA3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.